DYN
NASDAQDyne Therapeutics Inc.
Price$18.28-0.34 (-1.83%)
01:30 PM07:45 PM
News · 26 weeks83+81%
2025-10-262026-04-19
Mix5390d
- SEC Filings26(49%)
- Insider17(32%)
- Other9(17%)
- Leadership1(2%)
Latest news
25 items- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- INSIDERDirector Kersten Dirk sold $219,170 worth of shares (10,952 units at $20.01) as part of a pre-agreed trading plan (SEC Form 4)4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)
- SECSEC Form DEFA14A filed by Dyne Therapeutics Inc.DEFA14A - Dyne Therapeutics, Inc. (0001818794) (Filer)
- SECSEC Form DEF 14A filed by Dyne Therapeutics Inc.DEF 14A - Dyne Therapeutics, Inc. (0001818794) (Filer)
- PRDyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 18 new employees. The awards were made as an inducement material to the new employees' acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 320,900 shares of Dyne's common stock at a per share exercise price equal to the closing price of Dyne's common stock on The Nasdaq
- INSIDERSEC Form 4 filed by Rhodes Jason P4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- INSIDERSEC Form 4 filed by Kersten Dirk4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SECSEC Form 144 filed by Dyne Therapeutics Inc.144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- INSIDERSEC Form 4 filed by Kersten Dirk4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)
- SECSEC Form PRE 14A filed by Dyne Therapeutics Inc.PRE 14A - Dyne Therapeutics, Inc. (0001818794) (Filer)